No black box warning on record for Losartan

As of the latest FDA labeling reviewed, Losartan (losartan potassium) does not carry a black box warning. Standard warnings and precautions still apply — see the full Losartan medicine page for the complete safety profile.

Other warnings & precautions

Pregnancy Category D (2nd and 3rd Trimester): Medicines that directly affect the renin-angiotensin system can cause fetal injury and death. DISCONTINUE immediately when pregnancy is detected. ACE inhibitors and ARBs can cause oligohydramnios, fetal renal failure, and skull hypoplasia.
Hyperkalemia Risk: Monitor serum potassium in patients with CKD, diabetes, or on potassium-sparing diuretics.
Renal Impairment: ARBs can cause acute kidney failure in patients with bilateral renal artery stenosis or stenosis of a single functioning kidney.
Hypotension: First-dose hypotension can occur, particularly in volume-depleted or sodium-depleted patients (on diuretics). Start at 25mg in these patients.

No black box warning on record for Losartan

Other warnings & precautions

Pregnancy Category D (2nd and 3rd Trimester): Medicines that directly affect the renin-angiotensin system can cause fetal injury and death. DISCONTINUE immediately when pregnancy is detected. ACE inhibitors and ARBs can cause oligohydramnios, fetal renal failure, and skull hypoplasia.
Hyperkalemia Risk: Monitor serum potassium in patients with CKD, diabetes, or on potassium-sparing diuretics.
Renal Impairment: ARBs can cause acute kidney failure in patients with bilateral renal artery stenosis or stenosis of a single functioning kidney.
Hypotension: First-dose hypotension can occur, particularly in volume-depleted or sodium-depleted patients (on diuretics). Start at 25mg in these patients.

Losartan Black Box Warning

No black box warning on record for Losartan

Other warnings & precautions

Losartan Black Box Warning

No black box warning on record for Losartan

Other warnings & precautions